Titlebook: Additive Manufacturing in Pharmaceuticals; Subham Banerjee Book 2023 The Editor(s) (if applicable) and The Author(s), under exclusive lice

Bumptious

不足的东西

Machine Learning in Additive Manufacturing of Pharmaceuticals,rojections, the number of dementia cases will dramatically rise from 13.5 million cases in 2000 to 21.2 million in 2025 and 36.7 million in 2050. Medical advancements have increased human life expectancy and led to a rise in neurodegenerative disorders, which pose a growing social and economic burde

avenge

Book 2023al AM. This book is indeed a valuable resource for students, researchers/scholars, young start-ups/entrepreneurs, and pharmaceutical professionals by providing thorough detailing about AM in Pharmaceuticals..

Cpr951

Pcos971

https://doi.org/10.1007/978-981-19-5658-4chloramphenicol, prednisolone, aspirin, and berberine have been successfully 3D printed. In addition, soft devices for drug release have also been 3D printed. However, unexpected reactions have been reported in the literature which emphasize the cautionary aspect of 3D printing pharmaceuticals using

Acetaldehyde

Multiprotocol Label Switching (MPLS),ine-tuning of various process parameters. An added benefit of this powder bed fusion technology is that, it allows the fabrication of any solid oral dosage form in just a single step without use of any solvent, which turns this technique of rapid prototyping into green technology. Thus, the purpose

Rotator-Cuff

Advanced Encryption Standard (AES),ameters of the printing process, such as printing speed, infill pattern and number of layers. Due to this versatility, SSE has become a powerful tool to produce innovative dosage forms with clinical relevance for specific groups, including paediatric, geriatric and veterinary populations, as persona

GIST

乐章

一再遛